Hycamtin 4 mg, Lyophilisat

7680538570270 CH-53857 Lyophilisat
Hycamtin 4 mg, Lyophilisat
Hycamtin 4 mg, Lyophilisat
Hycamtin 4 mg, Lyophilisat
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lyophilisat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/06/2026
Summary of Product Characteristics
Français
20/06/2026
Summary of Product Characteristics
Italien
20/06/2026

Detailed composition

Substance Quantity Type Category
topotecanum
4.0 MG Substance Wirkstoff (Principe actif)
topotecani hydrochloridum
- Substance WIZUS
acidum tartaricum
- Substance HNIDK
mannitolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
1.68 MG Substance HBESI

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
53857
Drug name
Hycamtin, Lyophilisat
Galenic form
PULPA
ATC Code
L01XX17
Authorization status
Z
Dispensing category
A
First authorization
16/10/1996
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Ovarialkarzinom, kleinzelliges Bronchialkarzinom, Zervixkarzinom

Package details

Description (FR)
HYCAMTIN subst sèche 4 mg flac
Description (DE)
HYCAMTIN Trockensub 4 mg Durchstf
Market launch
16/10/1996
Market withdrawal
06/03/2026
Narcotic (BTM)
No

Other package sizes (2)

HYCAMTIN subst sèche 4 mg flac 5 pce
5 DUR
GTIN: 7680538570195
View
HYCAMTIN subst sèche 1 mg flac
1 DUR
GTIN: 7680538570355
View
Buy us a coffee Explore the data